Drug Shortage Report for SODIUM BICARBONATE INJECTION, USP
Report ID | 124369 |
Drug Identification Number | 02486628 |
Brand name | SODIUM BICARBONATE INJECTION, USP |
Common or Proper name | Sodium Bicarbonate Injection |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM BICARBONATE |
Strength(s) | 42MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 4.2%, 2.5 mEq (mmol), 5 mL Vial |
ATC code | B05XA |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-09-15 |
Estimated end date | Unknown |
Actual end date | 2020-12-05 |
Shortage status | Resolved |
Updated date | 2021-01-26 |
Company comments | Fresenius Kabi Canada Ltd. regrets to advise that due to unforeseen circumstances, our Sodium Bicarbonate Injection, USP, 4.2%, 2.5 mEq (mmol), 5 mL Vial is on backorder, effective today. We are working with our production site to expedite receipt of our next shipment. UPDATE Available 12/05/2020 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2021-01-26 | French | Compare |
v3 | 2021-01-26 | English | Compare |
v2 | 2020-09-17 | French | Compare |
v1 | 2020-09-17 | English | Compare |
Showing 1 to 4 of 4